Reduced bone density in patients with inflammatory bowel disease

Area of Science:

• Bone Metabolism
• Gastroenterology
• Endocrinology

Background:

• Inflammatory bowel disease (IBD) is associated with reduced bone mineral density.
• Potential causes include calcium homeostasis disruption and corticosteroid therapy.
• This study investigates IBD patients without typical risk factors for low bone density.

Purpose of the Study:

• To determine the prevalence of reduced bone mineral density in IBD patients.
• To explore the underlying mechanisms of bone loss in this population.
• To assess 79 IBD patients (Crohn's disease and ulcerative colitis) with no significant risk factors.

Main Methods:

• Dual-energy X-ray absorptiometry (DXA) for bone mineral density measurement.
• Analysis of serum and urinary markers for bone turnover (osteoblast and osteoclast activity).
• Assessment of bone resorption and formation markers.

Main Results:

• High prevalence of low bone mineral density (51%-77% T scores < -1.0; 17%-28% T scores < -2.5).
• Hips were more affected than vertebrae (p < 0.001).
• Increased bone resorption without compensatory bone formation; normal calcium homeostasis; no correlation with corticosteroid use or disease characteristics.

Conclusions:

• Reduced bone mineral density is common in IBD patients, especially in the hip.
• The mechanism involves increased bone resorption without increased formation, differing from other metabolic bone diseases.
• Findings suggest a unique pathway of bone loss in IBD.